Cancer drug targets

#Cancer drug targets #Cancer research #Cancer therapeutics #FDA #Oncology

New DDW Highlights podcast: 19 August 2024

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. The chosen news highlights this week all feature advances in drug development in oncology… Read More

#News

#Cancer drug targets #Cancer research #Cancer therapeutics #FDA #Oncology

New DDW Highlights vodcast: 19 August 2024

Every week, DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates in the DDW Highlights podcast. It is now also available in a concise vodcast format.   The chosen news highlights this… Read More

#News

#Cancer drug targets #Cancer research #Cancer therapeutics #FDA #Oncology

This week in drug discovery (12-16 August) 

News round-up for 12-16 August by DDW Senior Digital Content Editor Diana Spencer. The chosen news highlights this week all feature advances in drug development in oncology indications and reflect the breadth of therapeutic approaches to cancer treatment. The top stories: Genetic causes of… Read More

#News

Cancer cells
#Cancer drug targets #Genetics / genomics #Institute of Cancer Research #Oncology #University of Cambridge #Wellcome Sanger Institute

Researchers identify potential new genetic target for cancer drugs

UK researchers have mapped the exact variants in a gene that dramatically increase a person’s risk of developing cancer, paving the way for targeted treatment across diverse populations. Over 5,000 genetic variants that enable certain cancers to thrive were identified, along with a potential therapeutic target… Read More

#Cancer Research #News #Trending News

#Cancer drug targets #Cancer research #eFFECTOR #Immunology #Selective Translation Regulator Inhibitor (STRI)

New podcast episode: Depriving cancer of what it needs

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Steve Worland,… Read More

#News

Melanoma or skin cancer
#3D imaging #Cancer drug targets #Drug targets #Oncology #Skin cancer #The Institute of Cancer Research

Discovery reveals two potential drug targets against skin cancer

Scientists have discovered how skin cancer cells shapeshift based on their environment – enabling them to spread through the body and cause a metastatic cancer. The discovery of two genes responsible for sensing the environment and adapting cell shape could offer potential new drug targets to… Read More

#Cancer Research #Editor's Choice #News

Cancer cells
#Cancer drug targets #Francis Crick Institute #Oncology #Treatment resistance

Study identifies new targets for cancer therapy

Researchers at the Francis Crick Institute in the UK have shed light on how cancer cells survive after being cut off from oxygen, a finding that could help to prevent cancer from becoming resistant to treatment. When oxygen supplies are low, most cells change which proteins… Read More

#Cancer Research #Editor's Choice #News

#Cancer #Cancer drug targets #Clinical trials #Drug discovery #Psychedelics

New DDW Highlights podcast: 6 November 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The news highlights this week feature a variety of exciting clinical trial… Read More

#News

#Cancer #Cancer drug targets #Clinical trials #Drug discovery #Psychedelics

This week in drug discovery (30 Oct-3 Nov)  

News round-up for 30 October – 3 November by DDW Editor Reece Armstrong My news highlights this week feature a variety of exciting clinical trial results and launches that are examining therapies for much-needed disease areas, new drug approvals and even a space mission with a pharma twist. Read More

#News

Cancer research
#Cancer drug targets #Cancer research #DDW Turning Science into Business Summit #Drug discovery #Events #Immunotherapy #Oncology

DDW announces Summit on advances in cancer research

Join DDW’s Megan Thomas and Reece Armstrong with sponsor Taconic Biosciences for the first DDW Turning Science into Business Summit, ‘Cancer research opportunities and advances’, on 16 November at 7AM PDT / 10AM EST / 3PM GMT / 4PM CET. This free 2-hour… Read More

#Cancer Research #News

Cancer metastasis
#Cancer drug targets #Cancer research #Drug resistance #Oncology #University of Queensland

Novel inhibitors could become new anticancer therapeutics

University of Queensland (UQ) researchers have identified a novel drug target with the potential to overcome drug resistance and prevent tumour regrowth in cancer patients. The newly identified molecule is not currently a target for treatment, opening the potential for drug development. “Drug resistance… Read More

#Cancer Research #News

#Cancer drug targets #Cancer research #Cancer vaccine #Immunotherapy #Lung cancer #Oncology

World Lung Cancer Day: Five drug discovery breakthroughs

This World Lung Cancer Day, DDW’s Diana Spencer takes a look at five 2023 discoveries that could transform the treatment of lung cancer in the near future. Allogeneic cell vaccines In July 2023, Lineage Cell Therapeutics and Cancer Research UK announced encouraging primary and secondary endpoint… Read More

#Cancer Research #News #Trending News

#Allergy #Alzheimer's #Antibodies #Artificial intelligence (AI) #Autism #Cancer drug targets #Cancer research #Drug development #Influenza #Microbiome #Monoclonal antibodies

New DDW Highlights episode live now

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  This week we have heard about a number of studies that demonstrate an inventive… Read More

#News

#Allergy #Alzheimer's #Antibodies #Artificial intelligence (AI) #Autism #Cancer drug targets #Cancer research #Drug development #Influenza #Microbiome #Monoclonal antibodies

This week in drug discovery (26-30 June)  

News round-up for 26-30 June by DDW Digital Content Editor Diana Spencer. This week we have heard about a number of studies that demonstrate an inventive solution to an old problem, either through the use of an original approach or new, advanced technology. Whether… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Cancer drug targets #Cancer research #Collaboration #Oncology #Partnership

AI-powered cancer simulations enable drug targeting

Cancer Research Horizons and biotech company Turbine have announced a partnership to solve complex diseases.   The partnership will utilise Turbine’s Simulated Cells platform to identify target patient populations who could benefit from CDC7 inhibitor therapy with Cancer Research Horizons’ lead compound CRT’2199.   CRT’2199 originates from Cancer Research Horizons’ Therapeutic Innovation. Read More

#Business & Investment #Cancer Research #News